Glenmark Recalls Indomethacin Capsules Due to Incorrect Dosage Labeling
Glenmark Pharmaceuticals is recalling Indomethacin Capsules 50 mg because the bottles display incorrect adult dosage instructions.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which indicates the product is unlikely to cause adverse health consequences. The issue is a minor labeling error regarding dosage instructions.
Plain-English summary
Glenmark Pharmaceuticals Inc., USA is recalling Indomethacin Capsules USP, 50 mg, 100-count bottles. The recall was initiated because the product bottles were incorrectly labeled with the usual adult dosage of "One or two capsules 2 or 3 times a day" instead of the correct dosage of "One capsule 2 or 3 times a day."
The affected product is a prescription-only medication manufactured by Glenmark Pharmaceuticals Ltd. in India for Glenmark Pharmaceuticals Inc., USA. The recall involves 109,080 bottles distributed nationwide in the United States. Specific lot numbers and expiration dates are listed in the recall notice, including lots expiring in July, August, October, and November 2019.
Consumers who have purchased this product should check their bottles for the incorrect dosage instructions. If the label states "One or two capsules 2 or 3 times a day," they should stop using the product and contact their healthcare provider or pharmacist for guidance.
The recalled product
- Product
- INDOMETHACIN (INDOMETHACIN)
- Brand
- INDOMETHACIN
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 109,080
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (15)
- Lot #: 19172776
- 19172794
- Exp 07/19
- 19173111
- 19173186
- 19173188
- 19173189
- Exp 08/19
- 19173852
- 19173878
- 19173893
- Exp 10/19
- 19174318
- 19174341
- Exp 11/19.
UPCs (2)
- 0368462406014
- 0368462302019
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · INDOMETHACIN
- ModerateIndomethacin Extended-Release Capsules recalled for cGMP deviations
FDA (Drugs) · 2025-06-11
- ModerateIndomethacin Extended-Release Capsules Recalled for cGMP Deviations
FDA (Drugs) · 2025-05-28
- ModerateGlenmark Pharmaceuticals Recalls Indomethacin Capsules for Manufacturing Deviations
FDA (Drugs) · 2025-04-16
- ModerateIndomethacin Extended-Release Capsules Recalled Due to Failed Dissolution Specifications
FDA (Drugs) · 2024-09-04
- HighPrescription Drug Indomethacin Recalled Due to Label Mix-Up
FDA (Drugs) · 2023-12-06
Same manufacturer · Glenmark Pharmaceuticals Inc., USA
See all →- ModerateAzelaic Acid Gel 15% Recalled Over Grainy, Gritty, or Sandy Texture
FDA (Drugs) · 2026-08-05
- ModerateAlyacen 7/7/7 birth control tablets failed total impurities specification
FDA (Drugs) · 2026-06-24
- ModerateOndansetron tablets recalled because blister packs are not fully sealed
FDA (Drugs) · 2026-01-07
- CriticalFrozen chopped methi recalled after testing positive for Salmonella
FDA (Drugs) · 2025-12-17
- ModerateBisoprolol and hydrochlorothiazide tablets recalled over traces of another drug
FDA (Drugs) · 2025-12-10
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02